Chemotherapy use, performance status, and quality of life at the end of life
… association between patients’ performance status and the effect of chemotherapy on QOL in
the … with good performance status who receive additional palliative chemotherapy will have …
the … with good performance status who receive additional palliative chemotherapy will have …
Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non–small-cell lung cancer and a performance status of 2
R Lilenbaum, R Axelrod, S Thomas… - Journal of Clinical …, 2008 - ascopubs.org
Purpose A multicenter randomized phase II trial to evaluate two treatment strategies in the
first-line management of advanced non–small-cell lung cancer (NSCLC) patients with a …
first-line management of advanced non–small-cell lung cancer (NSCLC) patients with a …
Chemotherapy improves low performance status lung cancer patients
JP Sculier, JJ Lafitte, M Paesmans… - European …, 2007 - Eur Respiratory Soc
… chemotherapy is associated with clinical improvement in a substantial number of patients with
advanced nonsmall cell lung cancer of poor performance status. … , without standard control …
advanced nonsmall cell lung cancer of poor performance status. … , without standard control …
Role of chemotherapy in patients with poor performance status and advanced non-small cell lung cancer
C Langer, R Lilenbaum - Seminars in oncology, 2004 - Elsevier
… the use of chemotherapy still unanswered. It is now recognized that chemotherapy improves
… whether these benefits apply to patients with poor performance status (PS). These patients (…
… whether these benefits apply to patients with poor performance status (PS). These patients (…
Single-agent versus combination chemotherapy as first-line treatment for patients with advanced non-small cell lung cancer and performance status 2: a literature …
C Mörth, A Valachis - Lung Cancer, 2014 - Elsevier
… Treatment with platinum-based combination chemotherapy is considered standard of care
for patients with metastatic NSCLC and performance status (PS) 0–1 since it has been shown …
for patients with metastatic NSCLC and performance status (PS) 0–1 since it has been shown …
Meeting the chemotherapy needs of elderly and poor performance status patients with NSCLC
C Gridelli, J Hainsworth - Lung cancer, 2002 - Elsevier
… toxicity for combination chemotherapy. Based on these data, chemotherapy using the combination
… or vinorelbine, and single agent chemotherapy should remain the standard treatment. …
… or vinorelbine, and single agent chemotherapy should remain the standard treatment. …
[HTML][HTML] Chemotherapy for patients with advanced gastric cancer with performance status 2
… use combination chemotherapy regimens, including those containing standard doses of …
PS 2 patients from future trials that employ more toxic combination chemotherapy regimens. …
PS 2 patients from future trials that employ more toxic combination chemotherapy regimens. …
Variations in oncologist recommendations for chemotherapy for stage IV lung cancer: what is the role of performance status?
D Tisnado, J Malin, K Kahn, MB Landrum… - Journal of oncology …, 2016 - ascopubs.org
… have included patients with poor performance status. This study … chemotherapy by patient
performance status and symptoms and how physician characteristics influence chemotherapy …
performance status and symptoms and how physician characteristics influence chemotherapy …
Palliative care in poor-performance status small cell lung cancer patients: is there a mandatory role for chemotherapy?
CS Baldotto, EH Cronemberger, P de Biasi… - Supportive Care in …, 2012 - Springer
… Performance status, regardless of what scale was used, is one of the most efficient …
Nevertheless, so far, there are no data showing that our current standard chemotherapy approach is …
Nevertheless, so far, there are no data showing that our current standard chemotherapy approach is …
The effects of palliative chemotherapy in metastatic colorectal cancer patients with an ECOG performance status of 3 and 4
MC Teixeira, DF Marques, AC Ferrari, MFS Alves… - Clinical colorectal …, 2015 - Elsevier
… Anti-EGFR monoclonal antibodies are not standard in first-line therapy (we rather use them
… the combination of biologic agents with standard chemotherapy in patients with ECOG PS ≥ …
… the combination of biologic agents with standard chemotherapy in patients with ECOG PS ≥ …
相关搜索
- carboplatin based chemotherapy performance status
- role of chemotherapy performance status
- effects of palliative chemotherapy performance status
- first line chemotherapy performance status
- cell lung cancer performance status
- metastatic colorectal cancer performance status
- randomized phase performance status
- performance status patients with nsclc
- ecog performance status
- performance status score
- single agent performance status
- meta analysis performance status
- standard chemotherapy in patients performance status
- doublet chemotherapy performance status
- cytotoxic chemotherapy performance status
- combination chemotherapy performance status